Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

被引:40
|
作者
Dilley, James [1 ]
Burnell, Matthew [1 ]
Gentry-Maharaj, Aleksandra [1 ]
Ryan, Andy [1 ]
Neophytou, Christina [1 ]
Apostolidou, Sophia [1 ]
Karpinskyj, Chloe [1 ]
Kalsi, Jatinderpal [11 ]
Mould, Tim [2 ]
Woolas, Robert [3 ]
Singh, Naveena [4 ]
Widschwendter, Martin [11 ]
Fallowfield, Lesley [5 ]
Campbell, Stuart [6 ]
Skates, Steven J. [7 ,8 ]
McGuire, Alistair [9 ]
Parmar, Mahesh [1 ]
Jacobs, Ian [10 ]
Menon, Usha [1 ]
机构
[1] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, 2nd Floor, London WC1V 6LJ, England
[2] Univ Coll London Hosp, London, England
[3] Queen Alexandra Hosp, Portsmouth, Hants, England
[4] Barts Hlth NHS Trust, London, England
[5] Univ Sussex, Brighton & Sussex Med Sch, Sussex Hlth Outcomes Res & Educ Canc SHORE C, Brighton, E Sussex, England
[6] Create Hlth London, London, England
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] London Sch Econ, London, England
[10] Univ New South Wales, Sydney, NSW, Australia
[11] UCL, Inst Womens Hlth, London, England
基金
英国医学研究理事会;
关键词
Ovarian cancer; Symptoms; Routes to diagnosis; Survival; UKCTOCS; GOFF index; NICE; PREDICTIVE-VALUE; WOMEN; OUTCOMES; TIME; DELAY; STAGE;
D O I
10.1016/j.ygyno.2020.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. There are widespread efforts to increase symptom awareness of 'pelvic/abdominal pain, increased abdominal size/bloating, difficulty eating/feeling full and urinary frequency/urgency' in an attempt to diagnose ovarian cancer earlier. Long-term survival of women with these symptoms adjusted for known prognostic factors is yet to be determined. This study explored the association of symptoms, routes and interval to diagnosis and long-term survival in a population-based cohort of postmenopausal women diagnosed with invasive epithelial tubo-ovarian cancer (iE0C) in the 'no screen' (control) UKCTOCS arm. Methods. Of 101,299 women in the control arm. 574 were confirmed on outcome review to have iE0C between randomisation (2001-2005) and 31 December 2014. Data was extracted from medical notes and electronic records. A multivariable model was fitted for individual symptoms, time interval from symptom onset to diagnosis, route to diagnosis, speciality, morphological Type, age at diagnosis, year of diagnosis (period effect), stage, primary treatment, and residual disease. Results. Women presenting with symptoms listed in the NICE guidelines (HR1.48, 95%CI 1.16-1.89, p = 0.001) or the modified Goff Index (HR1- 68, 95%CI 1.32-2.13, p < 0.0001) had significantly worse survival than those who did not. Each additional presenting symptom decreased survival (HR1.20, 95%CI 1.12-1.28, p < 0.0001). In multivariable analysis, in addition to advanced stage, increasing residual disease and inadequate primary treatment, abdominal pain and loss of appetite/feeling full were significantly associated with increased mortality. Conclusions. The ovarian cancer symptom indices identify postmenopausal women with a poorer prognosis. This study however cannot exclude the possibility of better outcomes in those who are aware and act on their symptoms. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [1] Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial
    Narod, Steven A.
    Giannakeas, Vasily
    Sopik, Victoria
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 191 - 194
  • [2] Endometrial thickness and risk of cancer: a cohort study nested in the ultrasound arm of the UK Collaborative Trial for Ovarian Cancer Screening (UKCTOCS)
    Burnell, M.
    Gentry-Maharaj, A.
    Ryan, A.
    Glazer, C.
    Karpinskyj, C.
    Apostolidou, S.
    Kalsi, J.
    Campbell, S.
    Jacobs, I
    Menon, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 83 - 84
  • [3] Uk collaborative trial of ovarian cancer screening (UKCTOCS) psychosocial study
    Beveridge, H
    Fallowfield, L
    PSYCHO-ONCOLOGY, 2002, 11 (06) : 547 - 547
  • [4] OVERDIAGNOSIS OF BORDERLINE OVARIAN CANCER IN OVARIAN CANCER SCREENING: THE UK COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) EXPERIENCE
    Gentry-Maharaj, A.
    Karpinskyj, C.
    Taylor, H.
    Ryan, A.
    Singh, N.
    Benjamin, E.
    Widschwendter, M.
    Burnell, M.
    Davies, S.
    Kalsi, J.
    Skates, S.
    Campbell, S.
    Parmar, M.
    Jacobs, I.
    Menon, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 22 - 23
  • [5] Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
    Jacobs, Ian J.
    Menon, Usha
    Ryan, Andy
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Kalsi, Jatinderpal K.
    Amso, Nazar N.
    Apostolidou, Sophia
    Benjamin, Elizabeth
    Cruickshank, Derek
    Crump, Danielle N.
    Davies, Susan K.
    Dawnay, Anne
    Dobbs, Stephen
    Fletcher, Gwendolen
    Ford, Jeremy
    Godfrey, Keith
    Gunu, Richard
    Habib, Mariam
    Hallett, Rachel
    Herod, Jonathan
    Jenkins, Howard
    Karpinskyj, Chloe
    Leeson, Simon
    Lewis, Sara J.
    Liston, William R.
    Lopes, Alberto
    Mould, Tim
    Murdoch, John
    Oram, David
    Rabideau, Dustin J.
    Reynolds, Karina
    Scott, Ian
    Seif, Mourad W.
    Sharma, Aarti
    Singh, Naveena
    Taylor, Julie
    Warburton, Fiona
    Widschwendter, Martin
    Williamson, Karin
    Woolas, Robert
    Fallowfield, Lesley
    McGuire, Alistair J.
    Campbell, Stuart
    Parmar, Mahesh
    Skates, Steven J.
    LANCET, 2016, 387 (10022): : 945 - 956
  • [6] Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): A randomised controlled trial
    Jacobs, Ian J.
    Menon, Usha
    Ryan, Andy
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Kalsi, Jatinderpal K.
    McGuire, Alistair J.
    Farmer, Mahesh
    Skates, Steven J.
    CANCER RESEARCH, 2016, 76
  • [7] Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomized Controlled Trial
    Jacobs, Ian J.
    Menon, Usha
    Ryan, Andy
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Kalsi, Jatinderpal K.
    Amso, Nazar N.
    Apostolidou, Sophia
    Benjamin, Elizabeth
    Cruickshank, Derek
    Crump, Danielle N.
    Davies, Susan K.
    Dawnay, Anne
    Dobbs, Stephen
    Fletcher, Gwendolen
    Ford, Jeremy
    Godfrey, Keith
    Gunu, Richard
    Habib, Mariam
    Hallett, Rachel
    Herod, Jonathan
    Jenkins, Howard
    Karpinskyj, Chloe
    Leeson, Simon
    Lewis, Sara J.
    Liston, William R.
    Lopes, Alberto
    Mould, Tim
    Murdoch, John
    Oram, David
    Rabideau, Dustin J.
    Reynolds, Karina
    Scott, Ian
    Seif, Mourad W.
    Sharma, Aarti
    Singh, Naveena
    Taylor, Julie
    Warburton, Fiona
    Widschwendter, Martin
    Williamson, Karin
    Woolas, Robert
    Fallowfield, Lesley
    McGuire, Alistair J.
    Campbell, Stuart
    Parmar, Mahesh
    Skates, Steven J.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2016, 71 (06) : 346 - 348
  • [8] SYMPTOMS REPORTED BY WOMEN WITH SCREEN DETECTED INVASIVE EPITHELIAL OVARIAN CANCER IN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS)
    Dilley, J.
    Allen, P.
    Gentry-Maharaj, A.
    Apostolidou, S.
    Ryan, A.
    Kalsi, J.
    Burnell, M.
    Davies, S.
    Singh, N.
    Widschwendter, M.
    Campbell, S.
    Parmar, M.
    Skates, S.
    Jacobs, I.
    Menon, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 423 - 424
  • [9] The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Usha Menon
    Alistair J McGuire
    Maria Raikou
    Andy Ryan
    Susan K Davies
    Matthew Burnell
    Aleksandra Gentry-Maharaj
    Jatinderpal K Kalsi
    Naveena Singh
    Nazar N Amso
    Derek Cruickshank
    Stephen Dobbs
    Keith Godfrey
    Jonathan Herod
    Simon Leeson
    Tim Mould
    John Murdoch
    David Oram
    Ian Scott
    Mourad W Seif
    Karin Williamson
    Robert Woolas
    Lesley Fallowfield
    Stuart Campbell
    Steven J Skates
    Mahesh Parmar
    Ian J Jacobs
    British Journal of Cancer, 2017, 117 : 619 - 627
  • [10] The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
    Menon, Usha
    McGuire, Alistair J.
    Raikou, Maria
    Ryan, Andy
    Davies, Susan K.
    Burnell, Matthew
    Gentry-Maharaj, Aleksandra
    Kalsi, Jatinderpal K.
    Singh, Naveena
    Amso, Nazar N.
    Cruickshank, Derek
    Dobbs, Stephen
    Godfrey, Keith
    Herod, Jonathan
    Leeson, Simon
    Mould, Tim
    Murdoch, John
    Oram, David
    Scott, Ian
    Seif, Mourad W.
    Williamson, Karin
    Woolas, Robert
    Fallowfield, Lesley
    Campbell, Stuart
    Skates, Steven J.
    Parmar, Mahesh
    Jacobs, Ian J.
    BRITISH JOURNAL OF CANCER, 2017, 117 (05) : 619 - 627